The Protein-Protein Interface Evolution Acts in a Similar Way to Antibody Affinity Maturation

被引:20
作者
Li, Bohua [3 ,4 ]
Zhao, Lei
Wang, Chong [5 ,6 ]
Guo, Huaizu [5 ,6 ]
Wu, Lan
Zhang, Xunming
Qian, Weizhu [3 ,4 ]
Wang, Hao [3 ,4 ]
Guo, Yajun [1 ,2 ,3 ,4 ,5 ,6 ]
机构
[1] Second Mil Med Univ, Int Joint Canc Inst, Shanghai 200433, Peoples R China
[2] Second Mil Med Univ, Gen Hosp 301, Ctr Canc, Shanghai 200433, Peoples R China
[3] Natl Engn Res Ctr Antibody Med, Shanghai 201203, Peoples R China
[4] Shanghai Key Lab Cell Engn & Antibody, Shanghai 201203, Peoples R China
[5] Shanghai Jiao Tong Univ, Minist Educ, Ctr Antibody Med, Sch Med, Shanghai 200025, Peoples R China
[6] Shanghai Jiao Tong Univ, Minist Educ, Ctr Antibody Med, Sch Pharm, Shanghai 200025, Peoples R China
基金
中国国家自然科学基金;
关键词
SOMATIC HYPERMUTATION; STRUCTURAL BASIS; RATIONAL DESIGN; RECOGNITION; INTERLEUKIN-2; REPERTOIRE; ANTIGEN;
D O I
10.1074/jbc.M109.076547
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Understanding the evolutionary mechanism that acts at the interfaces of protein-protein complexes is a fundamental issue with high interest for delineating the macromolecular complexes and networks responsible for regulation and complexity in biological systems. To investigate whether the evolution of protein-protein interface acts in a similar way as antibody affinity maturation, we incorporated evolutionary information derived from antibody affinity maturation with common simulation techniques to evaluate prediction success rates of the computational method in affinity improvement in four different systems: antibody-receptor, antibody-peptide, receptor-membrane ligand, and receptor-soluble ligand. It was interesting to find that the same evolutionary information could improve the prediction success rates in all the four protein-protein complexes with an exceptional high accuracy (>57%). One of the most striking findings in our present study is that not only in the antibody-combining site but in other protein-protein interfaces almost all of the affinity-enhancing mutations are located at the germline hotspot sequences (RGYW or WA), indicating that DNA hot spot mechanisms may be widely used in the evolution of protein-protein interfaces. Our data suggest that the evolution of distinct protein-protein interfaces may use the same basic strategy under selection pressure to maintain interactions. Additionally, our data indicate that classical simulation techniques incorporating the evolutionary information derived from in vivo antibody affinity maturation can be utilized as a powerful tool to improve the binding affinity of protein-protein complex with a high accuracy.
引用
收藏
页码:3865 / 3871
页数:7
相关论文
共 37 条
[1]   MOLECULAR EVENTS DURING MATURATION OF THE IMMUNE-RESPONSE TO OXAZOLONE [J].
BEREK, C ;
GRIFFITHS, GM ;
MILSTEIN, C .
NATURE, 1985, 316 (6027) :412-418
[2]   MUTATION DRIFT AND REPERTOIRE SHIFT IN THE MATURATION OF THE IMMUNE-RESPONSE [J].
BEREK, C ;
MILSTEIN, C .
IMMUNOLOGICAL REVIEWS, 1987, 96 :23-41
[3]   Unnatural ligands for engineered proteins: New tools for chemical genetics [J].
Bishop, A ;
Buzko, O ;
Heyeck-Dumas, S ;
Jung, I ;
Kraybill, B ;
Liu, Y ;
Shah, K ;
Ulrich, S ;
Witucki, L ;
Yang, F ;
Zhang, C ;
Shokat, KM .
ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE, 2000, 29 :577-606
[4]   CHARMM - A PROGRAM FOR MACROMOLECULAR ENERGY, MINIMIZATION, AND DYNAMICS CALCULATIONS [J].
BROOKS, BR ;
BRUCCOLERI, RE ;
OLAFSON, BD ;
STATES, DJ ;
SWAMINATHAN, S ;
KARPLUS, M .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 1983, 4 (02) :187-217
[5]   HUMANIZATION OF AN ANTI-P185HER2 ANTIBODY FOR HUMAN CANCER-THERAPY [J].
CARTER, P ;
PRESTA, L ;
GORMAN, CM ;
RIDGWAY, JBB ;
HENNER, D ;
WONG, WLT ;
ROWLAND, AM ;
KOTTS, C ;
CARVER, ME ;
SHEPARD, HM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (10) :4285-4289
[6]   Affinity enhancement of an in vivo matured therapeutic antibody using structure-based computational design [J].
Clark, LA ;
Boriack-Sjodin, PA ;
Eldredge, J ;
Fitch, C ;
Friedman, B ;
Hanf, KJM ;
Jarpe, M ;
Liparoto, SF ;
Li, Y ;
Lugovskoy, A ;
Miller, S ;
Rushe, M ;
Sherman, W ;
Simon, K ;
Van Vlijmen, H .
PROTEIN SCIENCE, 2006, 15 (05) :949-960
[7]   Trends in antibody sequence changes during the somatic hypermutation process [J].
Clark, Louis A. ;
Ganesan, Skanth ;
Papp, Sarah ;
van Vlijmen, Herman W. T. .
JOURNAL OF IMMUNOLOGY, 2006, 177 (01) :333-340
[8]   Analysis of the antigen combining site: Correlations between length and sequence composition of the hypervariable loops and the nature of the antigen [J].
Collis, AVJ ;
Brouwer, AP ;
Martin, ACR .
JOURNAL OF MOLECULAR BIOLOGY, 2003, 325 (02) :337-354
[9]   Interactions of protein antigens with antibodies [J].
Davies, DR ;
Cohen, GH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (01) :7-12
[10]   Structural basis for recognition of CD20 by therapeutic antibody rituximab [J].
Du, Jiamu ;
Wang, Hao ;
Zhong, Chen ;
Peng, Baozhen ;
Zhang, Meilan ;
Li, Bohua ;
Huo, Sheng ;
Guo, Yajun ;
Ding, Jianping .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (20) :15073-15080